Abstract
The suppressive function of regulatory T-cells (Treg) requires precise control to allow an efficient adaption of the T-cell response to the requirements of the immune defense. In the setting of infection, an abrogation of the suppressive effect of Treg on the activation and proliferation of T-effector (Teff) cells is a central precondition to allow fast and efficient clearance of the infectious agent. Experimentally, the suppressive function of Treg on Teff can be indirectly measured in coculture proliferation assays. This versatile tool provides a readout of T cell proliferation in the presence of Treg through the measurement of a proliferation marker such as the incorporation of radioactively labeled thymidine (3H Thymidine), carboxyfluorescein succinimidyl ester (CFSE) or 5-Bromo-2′-deoxyuridine (BrdU). In a modular approach, the culture conditions can thereby be adapted to evaluate the effect of any cell type, live and inactivated microorganisms, molecularly defined immunostimulatory ligands, and cytokines on the interplay of Teff and Treg function. Here, we demonstrate how the suppression assay can be used as a multifunctional tool to provide insights into the interaction of Treg with Teff under a variety of conditions in vitro.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bopp T, Becker C, Klein M et al (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204:1303–1310
Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6: 295–307
Collison LW, Chaturvedi V, Henderson AL et al (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11:1093–1101
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057–1061
Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457–462
Fontenot JD, Rasmussen JP, Williams LM et al (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329–341
Thornton AM, Shevach EM (1998) CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287–296
Takahashi T, Kuniyasu Y, Toda M et al (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10:1969–1980
Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell mediated suppression by dendritic cells. Science 299:1033–1036
Kabelitz D, Wesch D, Oberg HH (2006) Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit Rev Immunol 26:291–306
Anz D, Koelzer VH, Moder S et al (2010) Immunostimulatory RNA blocks suppression by regulatory T cells. J Immunol 184:939–946
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-k B transcription factor. Mol Cell Biol 10:2327–2334
Hornung V, Guenthner-Biller M, Bourquin C et al (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 3:263–270
Caramalho I, Lopes-Carvalho T, Ostler D et al (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197:403–411
Peng G, Guo Z, Kiniwa Y et al (2005) Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309: 1380–1384
Sutmuller RP, den Brok MH, Kramer M et al (2006) Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116:485–494
Kurooka M, Kaneda Y (2007) Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res 67: 227–236
Wurzenberger C, Koelzer VH, Schreiber S et al (2009) Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo. Cancer Immunol Immunother 58:901–913
Rußmann E (1993) Colloquium Roche Mol Biochem 4:1–4
Crellin NK, Garcia RV, Hadisfar O et al (2005) Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 175:8051–8059
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Koelzer, V.H., Anz, D. (2014). A Modular Approach to Suppression Assays: TLR Ligands, Conditioned Medium, and Viral Infection. In: Anders, HJ., Migliorini, A. (eds) Innate DNA and RNA Recognition. Methods in Molecular Biology, vol 1169. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0882-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0882-0_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0881-3
Online ISBN: 978-1-4939-0882-0
eBook Packages: Springer Protocols